ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 043,00
0,06%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Interpace Biosciences Inc (QX) (IDXG)

  7. Interpace Biosciences Inc (QX) (IDXG) Actualités

IDXG

Interpace Biosciences (QX) (IDXG)

Interpace Biosciences Inc (QX)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:IDXG
DateHeureSourceTitreSymboleSociété
09/05/202422h29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
12/02/202423h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:IDXGInterpace Biosciences Inc (QX)
06/02/202412h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
08/11/202322h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
22/09/202322h53Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:IDXGInterpace Biosciences Inc (QX)
22/09/202322h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:IDXGInterpace Biosciences Inc (QX)
12/05/202322h35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
12/05/202322h24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
03/05/202321h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IDXGInterpace Biosciences Inc (QX)
28/04/202322h20Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:IDXGInterpace Biosciences Inc (QX)
27/03/202322h40Edgar (US Regulatory)Annual Report (10-k)USOTC:IDXGInterpace Biosciences Inc (QX)
20/09/202222h47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:IDXGInterpace Biosciences Inc (QX)
20/09/202222h37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
09/09/202222h29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
02/02/202222h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IDXGInterpace Biosciences Inc (QX)
01/02/202216h16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:IDXGInterpace Biosciences Inc (QX)
13/01/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:IDXGInterpace Biosciences Inc (QX)
13/01/202212h05Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)USOTC:IDXGInterpace Biosciences Inc (QX)
26/04/202114h53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:IDXGInterpace Biosciences Inc (QX)
01/03/202122h07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:IDXGInterpace Biosciences Inc (QX)
 Showing the most relevant articles for your search:USOTC:IDXG

Dernières Valeurs Consultées

NYSE
NKE
Nike
NASDAQ
AAPL
Apple
EU
SGO
Cie de SaintGobain
EU
LR
Legrand
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
EU
BNP
BNP Paribas
NYSE
KO
Coca Cola
EU
EN
Bouygues
EU
ACA
Credit Agricole
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés